Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Carter Gould's Stock Ratings
Cantor Fitzgerald Analyst
Carter Gould is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/20/2025
Overall Average Return
-0.44%
Smart Score
Overall Average Return Percentile
36th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/06/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $440.87 | 21.35% | Carter Gould55% | $535 → $535 | Reiterates | Overweight → Overweight | Get Alert |
| 04/23/2025 | BMY | Buy Now | Bristol-Myers Squibb | $46.91 | 17.25% | Carter Gould55% | $55 → $55 | Reiterates | Neutral → Neutral | Get Alert |
| 04/22/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $440.87 | 21.35% | Carter Gould55% | → $535 | Assumes | → Overweight | Get Alert |
| 04/22/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | 36.35% | Carter Gould55% | → $695 | Assumes | → Overweight | Get Alert |
| 04/22/2025 | PFE | Buy Now | Pfizer | $24.00 | — | Carter Gould55% | → $24 | Initiates | → Neutral | Get Alert |
| 04/22/2025 | PCVX | Buy Now | Vaxcyte | $32.87 | — | Carter Gould55% | — | Initiates | → Overweight | Get Alert |
| 04/22/2025 | MRK | Buy Now | Merck & Co | $78.88 | 7.76% | Carter Gould55% | → $85 | Initiates | → Neutral | Get Alert |
| 04/22/2025 | LLY | Buy Now | Eli Lilly | $762.30 | 27.9% | Carter Gould55% | → $975 | Initiates | → Overweight | Get Alert |
| 04/22/2025 | GILD | Buy Now | Gilead Sciences | $109.15 | 14.52% | Carter Gould55% | → $125 | Assumes | → Overweight | Get Alert |
| 04/22/2025 | BMY | Buy Now | Bristol-Myers Squibb | $46.91 | 17.25% | Carter Gould55% | → $55 | Assumes | → Neutral | Get Alert |
| 04/22/2025 | ABBV | Buy Now | AbbVie | $184.50 | 13.82% | Carter Gould55% | → $210 | Initiates | → Overweight | Get Alert |
| 12/23/2024 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | 30.38% | Carter Gould55% | $160 → $165 | Maintains | Overweight | Get Alert |
| 11/07/2024 | GILD | Buy Now | Gilead Sciences | $109.15 | -12.96% | Carter Gould55% | $84 → $95 | Maintains | Equal-Weight | Get Alert |
| 11/01/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | 108.94% | Carter Gould55% | $1080 → $1065 | Maintains | Overweight | Get Alert |
| 11/01/2024 | TVTX | Buy Now | Travere Therapeutics | $14.31 | 39.76% | Carter Gould55% | $18 → $20 | Maintains | Overweight | Get Alert |
| 10/31/2024 | LLY | Buy Now | Eli Lilly | $762.30 | 27.9% | Carter Gould55% | $1025 → $975 | Maintains | Overweight | Get Alert |
| 10/31/2024 | BIIB | Buy Now | Biogen | $127.04 | 41.69% | Carter Gould55% | $190 → $180 | Maintains | Equal-Weight | Get Alert |
| 10/23/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | 111.88% | Carter Gould55% | $1220 → $1080 | Maintains | Overweight | Get Alert |
| 10/07/2024 | BMY | Buy Now | Bristol-Myers Squibb | $46.91 | -8.34% | Carter Gould55% | $42 → $43 | Maintains | Underweight | Get Alert |
| 10/07/2024 | MRK | Buy Now | Merck & Co | $78.88 | 77.48% | Carter Gould55% | $142 → $140 | Maintains | Overweight | Get Alert |
| 10/07/2024 | GILD | Buy Now | Gilead Sciences | $109.15 | -23.04% | Carter Gould55% | $76 → $84 | Maintains | Equal-Weight | Get Alert |
| 10/07/2024 | AMGN | Buy Now | Amgen | $289.33 | 8.87% | Carter Gould55% | $300 → $315 | Maintains | Equal-Weight | Get Alert |
| 10/07/2024 | ABBV | Buy Now | AbbVie | $184.50 | 14.91% | Carter Gould55% | $200 → $212 | Maintains | Overweight | Get Alert |
| 10/01/2024 | TVTX | Buy Now | Travere Therapeutics | $14.31 | 25.79% | Carter Gould55% | $14 → $18 | Maintains | Overweight | Get Alert |
| 09/09/2024 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | 26.43% | Carter Gould55% | $180 → $160 | Maintains | Overweight | Get Alert |
| 08/29/2024 | NUVL | Buy Now | Nuvalent | $75.00 | 33.33% | Carter Gould55% | → $100 | Initiates | → Overweight | Get Alert |
| 08/22/2024 | BMY | Buy Now | Bristol-Myers Squibb | $46.91 | -10.47% | Carter Gould55% | $41 → $42 | Maintains | Underweight | Get Alert |
| 08/14/2024 | VOR | Buy Now | Vor Biopharma | $0.24 | 1176.05% | Carter Gould55% | $10 → $3 | Maintains | Overweight | Get Alert |
| 08/02/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | 139.35% | Carter Gould55% | $1200 → $1220 | Maintains | Overweight | Get Alert |
| 08/02/2024 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | 42.24% | Carter Gould55% | $169 → $180 | Maintains | Overweight | Get Alert |
| 08/02/2024 | BIIB | Buy Now | Biogen | $127.04 | 49.56% | Carter Gould55% | $200 → $190 | Maintains | Equal-Weight | Get Alert |
| 08/02/2024 | TVTX | Buy Now | Travere Therapeutics | $14.31 | -2.17% | Carter Gould55% | $12 → $14 | Maintains | Overweight | Get Alert |
| 07/31/2024 | PFE | Buy Now | Pfizer | $24.00 | 33.33% | Carter Gould55% | $30 → $32 | Maintains | Equal-Weight | Get Alert |
| 07/31/2024 | MRK | Buy Now | Merck & Co | $78.88 | 80.02% | Carter Gould55% | $145 → $142 | Maintains | Overweight | Get Alert |
| 07/29/2024 | BMY | Buy Now | Bristol-Myers Squibb | $46.91 | -12.6% | Carter Gould55% | $41 → $41 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 07/26/2024 | ABBV | Buy Now | AbbVie | $184.50 | 8.4% | Carter Gould55% | $187 → $200 | Maintains | Overweight | Get Alert |
| 07/10/2024 | BMY | Buy Now | Bristol-Myers Squibb | $46.91 | -12.6% | Carter Gould55% | $43 → $41 | Maintains | Equal-Weight | Get Alert |
| 07/10/2024 | LLY | Buy Now | Eli Lilly and Co | $762.30 | 34.46% | Carter Gould55% | $913 → $1025 | Maintains | Overweight | Get Alert |
| 07/10/2024 | PFE | Buy Now | Pfizer | $24.00 | 25% | Carter Gould55% | $28 → $30 | Maintains | Equal-Weight | Get Alert |
| 07/10/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | 135.42% | Carter Gould55% | $1050 → $1200 | Maintains | Overweight | Get Alert |
| 06/13/2024 | BRNS | Buy Now | Barinthus Biotherapeutics | $0.86 | 248.84% | Carter Gould55% | $7 → $3 | Maintains | Overweight | Get Alert |
| 06/11/2024 | GERN | Buy Now | Geron | $1.52 | 492.07% | Carter Gould55% | → $9 | Initiates | → Overweight | Get Alert |
| 05/23/2024 | CYTK | Buy Now | Cytokinetics | $33.00 | 187.88% | Carter Gould55% | $100 → $95 | Maintains | Overweight | Get Alert |
| 05/03/2024 | AMGN | Buy Now | Amgen | $289.33 | 3.69% | Carter Gould55% | $230 → $300 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 05/02/2024 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | 33.54% | Carter Gould55% | $150 → $169 | Maintains | Overweight | Get Alert |
| 04/29/2024 | GILD | Buy Now | Gilead Sciences | $109.15 | -30.37% | Carter Gould55% | $80 → $76 | Maintains | Equal-Weight | Get Alert |
| 04/29/2024 | ABBV | Buy Now | AbbVie | $184.50 | 1.36% | Carter Gould55% | $195 → $187 | Maintains | Overweight | Get Alert |
| 04/26/2024 | BMY | Buy Now | Bristol-Myers Squibb | $46.91 | -8.34% | Carter Gould55% | $51 → $43 | Maintains | Equal-Weight | Get Alert |
| 04/25/2024 | BIIB | Buy Now | Biogen | $127.04 | 57.43% | Carter Gould55% | $215 → $200 | Maintains | Equal-Weight | Get Alert |
| 04/16/2024 | SKIL | Buy Now | Skillsoft | $13.96 | 43.27% | Carter Gould55% | $25 → $20 | Maintains | Overweight | Get Alert |
| 04/04/2024 | BIIB | Buy Now | Biogen | $127.04 | 69.24% | Carter Gould55% | $230 → $215 | Maintains | Equal-Weight | Get Alert |
| 03/27/2024 | ABBV | Buy Now | AbbVie | $184.50 | 5.69% | Carter Gould55% | $185 → $195 | Maintains | Overweight | Get Alert |
| 02/29/2024 | ACLX | Buy Now | Arcellx | $63.00 | 15.87% | Carter Gould55% | $62 → $73 | Maintains | Overweight | Get Alert |
| 02/12/2024 | GILD | Buy Now | Gilead Sciences | $109.15 | -26.71% | Carter Gould55% | $85 → $80 | Maintains | Equal-Weight | Get Alert |
| 02/07/2024 | LLY | Buy Now | Eli Lilly | $762.30 | 6.26% | Carter Gould55% | $680 → $810 | Maintains | Overweight | Get Alert |
| 02/05/2024 | ABBV | Buy Now | AbbVie | $184.50 | 0.27% | Carter Gould55% | $175 → $185 | Maintains | Overweight | Get Alert |
| 02/02/2024 | MRK | Buy Now | Merck & Co | $78.88 | 83.82% | Carter Gould55% | $135 → $145 | Maintains | Overweight | Get Alert |
| 01/23/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | 100.11% | Carter Gould55% | $935 → $1020 | Maintains | Overweight | Get Alert |
| 01/23/2024 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | 18.53% | Carter Gould55% | $145 → $150 | Maintains | Overweight | Get Alert |
| 01/23/2024 | MRK | Buy Now | Merck & Co | $78.88 | 71.15% | Carter Gould55% | $130 → $135 | Maintains | Overweight | Get Alert |
| 01/23/2024 | GILD | Buy Now | Gilead Sciences | $109.15 | -22.13% | Carter Gould55% | $82 → $85 | Maintains | Equal-Weight | Get Alert |
| 01/23/2024 | LLY | Buy Now | Eli Lilly | $762.30 | -10.8% | Carter Gould55% | $630 → $680 | Maintains | Overweight | Get Alert |
| 01/23/2024 | ABBV | Buy Now | AbbVie | $184.50 | -5.15% | Carter Gould55% | $170 → $175 | Maintains | Overweight | Get Alert |
| 01/17/2024 | ALLK | Buy Now | Allakos | — | — | Carter Gould55% | $1.5 → $1 | Maintains | Underweight | Get Alert |
| 12/14/2023 | PFE | Buy Now | Pfizer | $24.00 | 16.67% | Carter Gould55% | $34 → $28 | Maintains | Equal-Weight | Get Alert |
| 12/06/2023 | SKIL | Buy Now | Skillsoft | $13.96 | 114.9% | Carter Gould55% | $37 → $30 | Maintains | Overweight | Get Alert |
| 11/16/2023 | ACLX | Buy Now | Arcellx | $63.00 | -1.59% | Carter Gould55% | $49 → $62 | Maintains | Overweight | Get Alert |
| 11/14/2023 | ALLK | Buy Now | Allakos | — | — | Carter Gould55% | $2.5 → $1.5 | Maintains | Underweight | Get Alert |
| 11/01/2023 | PFE | Buy Now | Pfizer | $24.00 | 41.67% | Carter Gould55% | $35 → $34 | Maintains | Equal-Weight | Get Alert |
| 10/30/2023 | ABBV | Buy Now | AbbVie | $184.50 | -7.86% | Carter Gould55% | $160 → $170 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/27/2023 | BMY | Buy Now | Bristol-Myers Squibb | $46.91 | 8.72% | Carter Gould55% | $60 → $51 | Maintains | Equal-Weight | Get Alert |
| 09/22/2023 | TVTX | Buy Now | Travere Therapeutics | $14.31 | -16.14% | Carter Gould55% | $31 → $12 | Maintains | Overweight | Get Alert |
| 08/21/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | 81.47% | Carter Gould55% | $900 → $925 | Maintains | Overweight | Get Alert |
| 08/18/2023 | SKIL | Buy Now | Skillsoft | $13.96 | -82.09% | Carter Gould55% | $2.9 → $2.5 | Maintains | Overweight | Get Alert |
| 08/09/2023 | LLY | Buy Now | Eli Lilly | $762.30 | -22.6% | Carter Gould55% | $500 → $590 | Maintains | Overweight | Get Alert |
| 08/08/2023 | BIIB | Buy Now | Biogen | $127.04 | 131.42% | Carter Gould55% | $311 → $294 | Maintains | Equal-Weight | Get Alert |
| 08/07/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | 76.57% | Carter Gould55% | $888 → $900 | Maintains | Overweight | Get Alert |
| 08/01/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Carter Gould55% | $110 → $172 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/28/2023 | BMY | Buy Now | Bristol-Myers Squibb | $46.91 | 32.17% | Carter Gould55% | $64 → $62 | Maintains | Equal-Weight | Get Alert |
| 07/24/2023 | GILD | Buy Now | Gilead Sciences | $109.15 | -26.71% | Carter Gould55% | $81 → $80 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | PFE | Buy Now | Pfizer | $24.00 | 58.33% | Carter Gould55% | $40 → $38 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | GILD | Buy Now | Gilead Sciences | $109.15 | -25.79% | Carter Gould55% | $84 → $81 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | BMY | Buy Now | Bristol-Myers Squibb | $46.91 | 36.43% | Carter Gould55% | $65 → $64 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | AMGN | Buy Now | Amgen | $289.33 | -27.42% | Carter Gould55% | $225 → $210 | Maintains | Underweight | Get Alert |
| 06/28/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | 74.21% | Carter Gould55% | $915 → $888 | Maintains | Overweight | Get Alert |
| 06/28/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Carter Gould55% | $98 → $110 | Maintains | Overweight | Get Alert |
| 06/08/2023 | BIIB | Buy Now | Biogen | $127.04 | — | Carter Gould55% | — | Maintains | Overweight | Get Alert |
| 06/07/2023 | SKIL | Buy Now | Skillsoft | $13.96 | -79.23% | Carter Gould55% | $3.5 → $2.9 | Maintains | Overweight | Get Alert |
| 05/11/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Carter Gould55% | $90 → $98 | Maintains | Overweight | Get Alert |
| 05/09/2023 | ACLX | Buy Now | Arcellx | $63.00 | -22.22% | Carter Gould55% | $38 → $49 | Maintains | Overweight | Get Alert |
| 05/05/2023 | ALEC | Buy Now | Alector | $1.54 | 679.22% | Carter Gould55% | $14 → $12 | Maintains | Overweight | Get Alert |
| 05/04/2023 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | -1.22% | Carter Gould55% | $131 → $125 | Maintains | Overweight | Get Alert |
| 05/03/2023 | PFE | Buy Now | Pfizer | $24.00 | 66.67% | Carter Gould55% | $43 → $40 | Maintains | Equal-Weight | Get Alert |
| 05/01/2023 | MRK | Buy Now | Merck & Co | $78.88 | 64.81% | Carter Gould55% | $128 → $130 | Maintains | Overweight | Get Alert |
| 05/01/2023 | LLY | Buy Now | Eli Lilly | $762.30 | -44.9% | Carter Gould55% | $400 → $420 | Maintains | Overweight | Get Alert |
| 05/01/2023 | BMY | Buy Now | Bristol-Myers Squibb | $46.91 | 38.56% | Carter Gould55% | $66 → $65 | Maintains | Equal-Weight | Get Alert |
| 05/01/2023 | AMGN | Buy Now | Amgen | $289.33 | -22.23% | Carter Gould55% | $227 → $225 | Maintains | Underweight | Get Alert |
| 04/26/2023 | BIIB | Buy Now | Biogen | $127.04 | 137.72% | Carter Gould55% | $307 → $302 | Maintains | Equal-Weight | Get Alert |
| 04/14/2023 | AMGN | Buy Now | Amgen | $289.33 | -21.54% | Carter Gould55% | $230 → $227 | Maintains | Underweight | Get Alert |
| 04/13/2023 | ABBV | Buy Now | AbbVie | $184.50 | -13.28% | Carter Gould55% | $155 → $160 | Maintains | Equal-Weight | Get Alert |
| 04/12/2023 | PFE | Buy Now | Pfizer | $24.00 | 79.17% | Carter Gould55% | $44 → $43 | Maintains | Equal-Weight | Get Alert |
| 04/12/2023 | SKIL | Buy Now | Skillsoft | $13.96 | -74.93% | Carter Gould55% | $4 → $3.5 | Maintains | Overweight | Get Alert |
| 03/24/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | 79.51% | Carter Gould55% | $815 → $915 | Maintains | Overweight | Get Alert |
| 03/21/2023 | GOSS | Buy Now | Gossamer Bio | $1.43 | 4.9% | Carter Gould55% | $2 → $1.5 | Maintains | Equal-Weight | Get Alert |
| 03/01/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Carter Gould55% | $50 → $90 | Maintains | Overweight | Get Alert |
| 02/21/2023 | TVTX | Buy Now | Travere Therapeutics | $14.31 | 116.63% | Carter Gould55% | $37 → $31 | Maintains | Overweight | Get Alert |
| 02/07/2023 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | 3.52% | Carter Gould55% | $136 → $131 | Maintains | Overweight | Get Alert |
| 02/01/2023 | AMGN | Buy Now | Amgen | $289.33 | -20.51% | Carter Gould55% | $240 → $230 | Maintains | Underweight | Get Alert |
| 02/01/2023 | PFE | Buy Now | Pfizer | $24.00 | 83.33% | Carter Gould55% | $49 → $44 | Maintains | Equal-Weight | Get Alert |
| 01/18/2023 | GILD | Buy Now | Gilead Sciences | $109.15 | -23.04% | Carter Gould55% | $76 → $84 | Maintains | Equal-Weight | Get Alert |
| 01/18/2023 | AMGN | Buy Now | Amgen | $289.33 | -17.05% | Carter Gould55% | $234 → $240 | Maintains | Underweight | Get Alert |
| 01/03/2023 | LLY | Buy Now | Eli Lilly | $762.30 | -47.53% | Carter Gould55% | $395 → $400 | Maintains | Overweight | Get Alert |
| 12/12/2022 | ACLX | Buy Now | Arcellx | $63.00 | -39.68% | Carter Gould55% | $25 → $38 | Maintains | Overweight | Get Alert |
| 12/07/2022 | GOSS | Buy Now | Gossamer Bio | $1.43 | 39.86% | Carter Gould55% | $18 → $2 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/30/2022 | BIIB | Buy Now | Biogen | $127.04 | 146.38% | Carter Gould55% | $275 → $313 | Maintains | Equal-Weight | Get Alert |
| 11/11/2022 | VOR | Buy Now | Vor Biopharma | $0.24 | 6280.26% | Carter Gould55% | $26 → $15 | Maintains | Overweight | Get Alert |
| 11/11/2022 | MTEM | Buy Now | Molecular Templates | $0.00 | 999900% | Carter Gould55% | $4.5 → $1 | Maintains | Overweight | Get Alert |
| 11/09/2022 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Carter Gould55% | $43 → $50 | Maintains | Overweight | Get Alert |
| 11/02/2022 | PFE | Buy Now | Pfizer | $24.00 | 104.17% | Carter Gould55% | $44 → $49 | Maintains | Equal-Weight | Get Alert |
| 11/02/2022 | LLY | Buy Now | Eli Lilly | $762.30 | -48.18% | Carter Gould55% | $355 → $395 | Maintains | Overweight | Get Alert |
| 10/31/2022 | ABBV | Buy Now | AbbVie | $184.50 | -15.99% | Carter Gould55% | $160 → $155 | Maintains | Equal-Weight | Get Alert |
| 10/31/2022 | GILD | Buy Now | Gilead Sciences | $109.15 | -30.37% | Carter Gould55% | $60 → $76 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 10/31/2022 | AMGN | Buy Now | Amgen | $289.33 | -19.12% | Carter Gould55% | → $234 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 10/28/2022 | MRK | Buy Now | Merck & Co | $78.88 | 39.45% | Carter Gould55% | $105 → $110 | Maintains | Overweight | Get Alert |
| 10/12/2022 | PFE | Buy Now | Pfizer | $24.00 | 83.33% | Carter Gould55% | $50 → $44 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | GILD | Buy Now | Gilead Sciences | $109.15 | -45.03% | Carter Gould55% | $56 → $60 | Maintains | Underweight | Get Alert |
| 10/12/2022 | BMY | Buy Now | Bristol-Myers Squibb | $46.91 | 40.69% | Carter Gould55% | $69 → $66 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | AMGN | Buy Now | Amgen | $289.33 | -19.12% | Carter Gould55% | $236 → $234 | Maintains | Equal-Weight | Get Alert |
| 10/07/2022 | BIIB | Buy Now | Biogen | $127.04 | 116.47% | Carter Gould55% | $200 → $275 | Maintains | Equal-Weight | Get Alert |
| 09/09/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | 59.89% | Carter Gould55% | $735 → $815 | Maintains | Overweight | Get Alert |
| 08/18/2022 | GOSS | Buy Now | Gossamer Bio | $1.43 | 1158.74% | Carter Gould55% | $12 → $18 | Maintains | Overweight | Get Alert |
| 08/16/2022 | APLT | Buy Now | Applied Therapeutics | $0.35 | 542.86% | Carter Gould55% | $2.5 → $2.25 | Maintains | Equal-Weight | Get Alert |
| 08/05/2022 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | -10.71% | Carter Gould55% | $110 → $113 | Maintains | Overweight | Get Alert |
| 08/01/2022 | PFE | Buy Now | Pfizer | $24.00 | 116.67% | Carter Gould55% | $50 → $52 | Maintains | Equal-Weight | Get Alert |
| 08/01/2022 | ABBV | Buy Now | AbbVie | $184.50 | -13.28% | Carter Gould55% | $174 → $160 | Maintains | Equal-Weight | Get Alert |
| 07/29/2022 | MRK | Buy Now | Merck & Co | $78.88 | 28.04% | Carter Gould55% | $97 → $101 | Maintains | Overweight | Get Alert |
| 07/21/2022 | BIIB | Buy Now | Biogen | $127.04 | 57.43% | Carter Gould55% | $210 → $200 | Maintains | Equal-Weight | Get Alert |
| 05/11/2022 | ALLK | Buy Now | Allakos | — | — | Carter Gould55% | $7 → $2.5 | Maintains | Underweight | Get Alert |
| 05/11/2022 | ALEC | Buy Now | Alector | $1.54 | 809.09% | Carter Gould55% | $42 → $14 | Maintains | Overweight | Get Alert |
| 05/04/2022 | BIIB | Buy Now | Biogen | $127.04 | 65.3% | Carter Gould55% | $219 → $210 | Maintains | Equal-Weight | Get Alert |
| 05/02/2022 | BMY | Buy Now | Bristol-Myers Squibb | $46.91 | 44.96% | Carter Gould55% | $66 → $68 | Maintains | Equal-Weight | Get Alert |
| 04/26/2022 | GOSS | Buy Now | Gossamer Bio | $1.43 | 739.16% | Carter Gould55% | $18 → $12 | Maintains | Overweight | Get Alert |
| 04/12/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | 46.16% | Carter Gould55% | $700 → $745 | Maintains | Overweight | Get Alert |
| 04/12/2022 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | -13.08% | Carter Gould55% | $100 → $110 | Maintains | Overweight | Get Alert |
| 04/12/2022 | MRK | Buy Now | Merck & Co | $78.88 | 22.97% | Carter Gould55% | $94 → $97 | Maintains | Overweight | Get Alert |
| 04/12/2022 | BIIB | Buy Now | Biogen | $127.04 | 72.39% | Carter Gould55% | $235 → $219 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | AMGN | Buy Now | Amgen | $289.33 | -18.43% | Carter Gould55% | $233 → $236 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | ABBV | Buy Now | AbbVie | $184.50 | -5.69% | Carter Gould55% | $150 → $174 | Maintains | Equal-Weight | Get Alert |
| 03/30/2022 | MTEM | Buy Now | Molecular Templates | $0.00 | 4499900% | Carter Gould55% | $8 → $4.5 | Maintains | Overweight | Get Alert |
| 03/21/2022 | VOR | Buy Now | Vor Biopharma | $0.24 | 10959.12% | Carter Gould55% | $56 → $26 | Maintains | Overweight | Get Alert |
| 03/21/2022 | APLT | Buy Now | Applied Therapeutics | $0.35 | 614.29% | Carter Gould55% | $7 → $2.5 | Maintains | Equal-Weight | Get Alert |
| 03/10/2022 | GILD | Buy Now | Gilead Sciences | $109.15 | -48.69% | Carter Gould55% | $63 → $56 | Maintains | Underweight | Get Alert |
| 02/09/2022 | AMGN | Buy Now | Amgen | $289.33 | -19.47% | Carter Gould55% | $228 → $233 | Maintains | Equal-Weight | Get Alert |
| 02/03/2022 | ABBV | Buy Now | AbbVie | $184.50 | -18.7% | Carter Gould55% | $133 → $150 | Maintains | Equal-Weight | Get Alert |
| 01/20/2022 | PAYC | Buy Now | Paycom Software | $232.15 | 63.69% | Carter Gould55% | $392 → $380 | Maintains | Equal-Weight | Get Alert |
| 01/20/2022 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | -20.98% | Carter Gould55% | $110 → $100 | Maintains | Overweight | Get Alert |
| 01/20/2022 | BIIB | Buy Now | Biogen | $127.04 | 92.07% | Carter Gould55% | $280 → $244 | Maintains | Equal-Weight | Get Alert |
| 01/20/2022 | ABBV | Buy Now | AbbVie | $184.50 | -27.91% | Carter Gould55% | $118 → $133 | Maintains | Equal-Weight | Get Alert |
| 01/04/2022 | APLT | Buy Now | Applied Therapeutics | $0.35 | 1900% | Carter Gould55% | $44 → $7 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/22/2021 | ALLK | Buy Now | Allakos | — | — | Carter Gould55% | $36 → $8 | Maintains | Underweight | Get Alert |
| 12/20/2021 | LLY | Buy Now | Eli Lilly | $762.30 | -57.37% | Carter Gould55% | $280 → $325 | Maintains | Overweight | Get Alert |
| 12/16/2021 | TVTX | Buy Now | Travere Therapeutics | $14.31 | 179.52% | Carter Gould55% | $36 → $40 | Maintains | Overweight | Get Alert |
| 12/10/2021 | PFE | Buy Now | Pfizer | $24.00 | 125% | Carter Gould55% | $44 → $54 | Maintains | Equal-Weight | Get Alert |
| 12/09/2021 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Carter Gould55% | $180 → $43 | Maintains | Overweight | Get Alert |
| 11/03/2021 | AMGN | Buy Now | Amgen | $289.33 | -21.2% | Carter Gould55% | $230 → $228 | Maintains | Equal-Weight | Get Alert |
| 11/01/2021 | MRK | Buy Now | Merck & Co | $78.88 | 19.17% | Carter Gould55% | $92 → $94 | Maintains | Overweight | Get Alert |
| 11/01/2021 | ABBV | Buy Now | AbbVie | $184.50 | -36.04% | Carter Gould55% | $112 → $118 | Maintains | Equal-Weight | Get Alert |
| 10/28/2021 | BMY | Buy Now | Bristol-Myers Squibb | $46.91 | 40.69% | Carter Gould55% | $68 → $66 | Maintains | Equal-Weight | Get Alert |
| 10/08/2021 | BMY | Buy Now | Bristol-Myers Squibb | $46.91 | 44.96% | Carter Gould55% | $71 → $68 | Maintains | Equal-Weight | Get Alert |
| 10/08/2021 | MRK | Buy Now | Merck & Co | $78.88 | 16.63% | Carter Gould55% | $87 → $92 | Maintains | Overweight | Get Alert |
| 10/08/2021 | BIIB | Buy Now | Biogen | $127.04 | 128.27% | Carter Gould55% | $395 → $290 | Maintains | Equal-Weight | Get Alert |
| 10/01/2021 | XLRN | Buy Now | Acceleron Pharma | — | — | Carter Gould55% | $150 → $180 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/06/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | 38.31% | Carter Gould55% | $675 → $705 | Maintains | Overweight | Get Alert |
| 07/20/2021 | CYTK | Buy Now | Cytokinetics | $33.00 | 21.21% | Carter Gould55% | $28 → $40 | Maintains | Overweight | Get Alert |
| 07/06/2021 | LLY | Buy Now | Eli Lilly | $762.30 | -67.2% | Carter Gould55% | $227 → $250 | Maintains | Overweight | Get Alert |
| 06/08/2021 | BIIB | Buy Now | Biogen | $127.04 | 210.93% | Carter Gould55% | $265 → $395 | Maintains | Equal-Weight | Get Alert |
| 05/06/2021 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | -13.08% | Carter Gould55% | → $110 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/28/2021 | LLY | Buy Now | Eli Lilly | $762.30 | -70.22% | Carter Gould55% | $232 → $227 | Maintains | Overweight | Get Alert |
| 04/26/2021 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Carter Gould55% | → $155 | Initiates | → Overweight | Get Alert |
| 03/05/2021 | AMGN | Buy Now | Amgen | $289.33 | -20.51% | Carter Gould55% | $242 → $230 | Maintains | Equal-Weight | Get Alert |
| 03/03/2021 | VOR | Buy Now | Vor Biopharma | $0.24 | 23719.65% | Carter Gould55% | → $56 | Initiates | → Overweight | Get Alert |
| 07/29/2020 | AMGN | Buy Now | Amgen | $289.33 | -13.59% | Carter Gould55% | $245 → $250 | Maintains | Equal-Weight | Get Alert |
| 07/29/2020 | ALEC | Buy Now | Alector | $1.54 | 1977.92% | Carter Gould55% | $36 → $32 | Maintains | Overweight | Get Alert |
| 06/22/2020 | BIIB | Buy Now | Biogen | $127.04 | 120.4% | Carter Gould55% | $370 → $280 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/07/2020 | NBIX | Buy Now | Neurocrine Biosciences | $126.55 | -14.66% | Carter Gould55% | $105 → $108 | Maintains | Equal-Weight | Get Alert |
| 04/29/2020 | PFE | Buy Now | Pfizer | $24.00 | 54.17% | Carter Gould55% | $36 → $37 | Maintains | Equal-Weight | Get Alert |
| 04/23/2020 | BIIB | Buy Now | Biogen | $127.04 | 191.25% | Carter Gould55% | $389 → $370 | Maintains | Overweight | Get Alert |
| 02/27/2020 | MTEM | Buy Now | Molecular Templates | $0.00 | 21999900% | Carter Gould55% | → $22 | Initiates | → Overweight | Get Alert |
| 02/27/2020 | GOSS | Buy Now | Gossamer Bio | $1.43 | 1368.53% | Carter Gould55% | → $21 | Initiates | → Overweight | Get Alert |
| 02/27/2020 | GILD | Buy Now | Gilead Sciences | $109.15 | -43.2% | Carter Gould55% | → $62 | Initiates | → Underweight | Get Alert |
| 02/27/2020 | APLT | Buy Now | Applied Therapeutics | $0.35 | 18185.71% | Carter Gould55% | → $64 | Initiates | → Overweight | Get Alert |
| 02/27/2020 | BMY | Buy Now | Bristol-Myers Squibb | $46.91 | 47.09% | Carter Gould55% | → $69 | Initiates | → Equal-Weight | Get Alert |
| 02/27/2020 | BIIB | Buy Now | Biogen | $127.04 | 206.2% | Carter Gould55% | → $389 | Initiates | → Overweight | Get Alert |
| 02/27/2020 | PFE | Buy Now | Pfizer | $24.00 | 50% | Carter Gould55% | → $36 | Initiates | → Equal-Weight | Get Alert |
| 02/27/2020 | XLRN | Buy Now | Acceleron Pharma | — | — | Carter Gould55% | → $107 | Initiates | → Overweight | Get Alert |
| 05/08/2019 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | -13.68% | Carter Gould55% | $480 → $440 | Maintains | Buy | Get Alert |
| 05/03/2019 | XLRN | Buy Now | Acceleron Pharma | — | — | Carter Gould55% | $54 → $45 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/10/2019 | GILD | Buy Now | Gilead Sciences | $109.15 | -29.45% | Carter Gould55% | $75 → $77 | Upgrade | Neutral → Buy | Get Alert |
| 04/01/2019 | CELG | Buy Now | Celgene | — | — | Carter Gould55% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/22/2019 | BIIB | Buy Now | Biogen | $127.04 | — | Carter Gould55% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/05/2019 | GOSS | Buy Now | Gossamer Bio | $1.43 | 1788.11% | Carter Gould55% | → $27 | Initiates | → Overweight | Get Alert |
| 03/04/2019 | ALEC | Buy Now | Alector | $1.54 | 1653.25% | Carter Gould55% | → $27 | Initiates | → Overweight | Get Alert |
| 01/16/2019 | INCY | Buy Now | Incyte | $68.25 | 20.15% | Carter Gould55% | $75 → $82 | Downgrade | Buy → Neutral | Get Alert |
| 07/26/2018 | VRTX | Buy Now | Vertex Pharmaceuticals | $440.87 | -57.36% | Carter Gould55% | $183 → $188 | Maintains | Neutral | Get Alert |
| 07/26/2018 | BIIB | Buy Now | Biogen | $127.04 | 210.93% | Carter Gould55% | $354 → $395 | Maintains | Buy | Get Alert |
| 04/12/2018 | INCY | Buy Now | Incyte | $68.25 | — | Carter Gould55% | — | Upgrade | Neutral → Buy | Get Alert |
| 01/31/2018 | BIIB | Buy Now | Biogen | $127.04 | — | Carter Gould55% | — | Upgrade | Neutral → Buy | Get Alert |
| 10/27/2017 | CELG | Buy Now | Celgene | — | — | Carter Gould55% | $146 → $120 | Maintains | Buy | Get Alert |
| 10/25/2017 | BIIB | Buy Now | Biogen | $127.04 | 150.31% | Carter Gould55% | $285 → $318 | Maintains | Neutral | Get Alert |
| 10/20/2017 | CELG | Buy Now | Celgene | — | — | Carter Gould55% | $153 → $146 | Maintains | Buy | Get Alert |
| 09/21/2017 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | -1.91% | Carter Gould55% | $535 → $500 | Maintains | Buy | Get Alert |
| 07/26/2017 | BIIB | Buy Now | Biogen | $127.04 | 124.34% | Carter Gould55% | $270 → $285 | Maintains | Neutral | Get Alert |
| 07/26/2017 | AMGN | Buy Now | Amgen | $289.33 | -36.06% | Carter Gould55% | $175 → $185 | Maintains | Neutral | Get Alert |
| 06/19/2017 | BIIB | Buy Now | Biogen | $127.04 | — | Carter Gould55% | — | Upgrade | Sell → Neutral | Get Alert |
| 03/09/2017 | XLRN | Buy Now | Acceleron Pharma | — | — | Carter Gould55% | → $36 | Initiates | → Buy | Get Alert |
| 03/09/2017 | GILD | Buy Now | Gilead Sciences | $109.15 | — | Carter Gould55% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/09/2017 | AMGN | Buy Now | Amgen | $289.33 | -36.06% | Carter Gould55% | → $185 | Initiates | → Neutral | Get Alert |
| 03/09/2017 | INCY | Buy Now | Incyte | $68.25 | 105.13% | Carter Gould55% | → $140 | Initiates | → Neutral | Get Alert |
| 03/09/2017 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | -14.66% | Carter Gould55% | → $435 | Initiates | → Buy | Get Alert |
| 02/10/2016 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | 12.81% | Carter Gould55% | $645 → $575 | Maintains | Buy | Get Alert |
| 09/07/2015 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | — | Carter Gould55% | — | Upgrade | Sell → Buy | Get Alert |
| 07/15/2015 | CELG | Buy Now | Celgene | — | — | Carter Gould55% | $130 → $142 | Maintains | Buy | Get Alert |
| 07/09/2015 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | — | Carter Gould55% | — | Downgrade | Neutral → Sell | Get Alert |
| 05/07/2014 | REGN | Buy Now | Regeneron Pharmaceuticals | $509.72 | -37.22% | Carter Gould55% | $310 → $320 | Maintains | Neutral | Get Alert |
| 12/05/2013 | CELG | Buy Now | Celgene | — | — | Carter Gould55% | $163 → $200 | Upgrade | Neutral → Buy | Get Alert |
| 08/02/2013 | INCY | Buy Now | Incyte | $68.25 | -58.97% | Carter Gould55% | $27 → $28 | Maintains | Buy | Get Alert |
| 04/12/2013 | CELG | Buy Now | Celgene | — | — | Carter Gould55% | $100 → $127 | Maintains | Neutral | Get Alert |
| 09/10/2012 | CELG | Buy Now | Celgene | — | — | Carter Gould55% | $78 → $80 | Downgrade | Buy → Neutral | Get Alert |
| 04/27/2012 | INCY | Buy Now | Incyte Genomics | $68.25 | -61.9% | Carter Gould55% | $22 → $26 | Maintains | Buy | Get Alert |
| 04/27/2012 | CELG | Buy Now | Celgene | — | — | Carter Gould55% | $88 → $85 | Maintains | Buy | Get Alert |
